Article
RRM2 is a potential prognostic biomarker with functional significance in glioma
1 Jan 2019
Abstract excerpt
Glioma is one of the most common brain tumors, suggesting the importance of investigating the molecular mechanism of gliomas. We studied the roles of Ribonucleotide Reductase Regulatory Subunit M2 (RRM2) in glioma. Expressions of RRM2 are higher in glioma tissues evidenced by TCGA data, western blot and immunohistochemistry. RRM2 is negatively correlated with glioma patient's survival. RNA-seq showed that genes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
